Eli Lilly and Company (LLY)

Number of days of payables

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Payables turnover		5.56	5.73	5.41	6.00	5.62	5.81	5.62	6.57	7.00	8.38	8.28	10.01	8.62	8.75	8.55	7.76	7.41	6.81	7.52	7.79
Number of days of payables	days	65.60	63.75	67.41	60.82	64.98	62.85	64.97	55.55	52.11	43.55	44.09	36.47	42.35	41.71	42.70	47.03	49.23	53.64	48.51	46.84

December 31, 2024 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 5.56
= 65.60

The number of days of payables for Eli Lilly and Company has shown fluctuations over the past several quarters. From March 31, 2020, to June 30, 2021, there was a general trend of decreasing number of days of payables, indicating that the company was taking less time to pay its suppliers.

However, from September 30, 2021, to December 31, 2024, there was a reversal in this trend, with the number of days of payables increasing steadily. This may imply that Eli Lilly and Company was taking longer to pay its suppliers during this period.

It is important to note that a decreasing number of days of payables may suggest that the company is managing its cash flow more efficiently by paying suppliers more quickly. Conversely, an increasing number of days of payables may indicate a potential strain on the company's liquidity or cash management practices.

Overall, a careful analysis of the number of days of payables, along with other financial metrics, would provide a more comprehensive understanding of Eli Lilly and Company's financial performance and operating efficiency.